Pain Point, Solved 4.9 ★★★★★ Google Rating

How Do Home Infusion Providers Manage Prior Auth When Medical and Pharmacy Benefits Split?

All Pain Points

Ask AI about this page

Home infusion providers manage split-benefit prior auth by treating every referral as two verifications, not one, because the same therapy can run under the medical benefit, the pharmacy benefit, or both depending on the payer, and the drug can approve under one while the nursing and per diem components sit unauthorized under the other. It is rarely that the therapy is not covered; it is that intake ran a single benefit path when the payer required parallel ones, so a piece of the claim starts life unbillable. The fix has four moves: verify both benefit structures on intake before anything ships, submit and track the medical-benefit and pharmacy-benefit authorizations as separate live tasks, match every authorization back to the exact components it covers before the claim goes out, and hold a start when a required auth is still open instead of treating and fighting the denial later. We run those moves inside the intake and billing systems you already use, so a referral does not begin until every payable piece is covered. The table of contents maps the whole method; the moves after it are the detail.

What Actually Keeps a Split-Benefit Infusion Start From Going Unbillable
Key Pain Points and Discussions by Providers
Why This Keeps Happening
The Solution
How We Permanently Fix the Process
The Whole Thing in Four Sentences
Frequently Asked Questions
Where the Claims on This Page Come From

What Actually Keeps a Split-Benefit Infusion Start From Going Unbillable

The goal is simple: every referral verified on both benefit paths, every required authorization in hand before the drug and the nurse are scheduled, and every auth matched to the claim components it covers. Here is what does that, move by move.

1. Verify Both Benefit Structures on Intake, Not One

Before anything ships, intake has to answer a question a single verification never asks: does this payer run the drug, the per diem, the nursing, and the supplies under the medical benefit, the pharmacy benefit, or split across both? For many plans, and especially Medicaid, the drug goes to the pharmacy benefit on an NCPDP claim while the service and supply side bills medical on a CMS-1500. If intake verifies only the path the referral arrived on, the other half of the therapy starts life uncovered. You cannot authorize a benefit you never checked.

2. Run the Medical and Pharmacy Authorizations as Two Live Tasks

Once you know the therapy splits, each side is its own authorization with its own portal, its own criteria, and its own clock. The pharmacy-benefit PA for the drug does not carry the nursing and per diem, and the medical-benefit auth for those components will not appear unless someone opens it. Tracking both as separate, named tasks, each with a submitted date, a status, and an owner, is what keeps one from quietly closing while the other is forgotten. One approval is not the referral cleared; it is half of it.

3. Match Every Authorization to the Claim Components It Covers

An approval number is not the same as a covered claim. Before the start, map each authorization to the exact components it pays for: this pharmacy PA covers the drug NDC, this medical auth covers the per diem and the skilled nursing visits, these supplies fall under this benefit. When the claim is built from that map, every line has an authorization behind it. When it is not, a five-figure infusion goes out with an unauthorized nursing component and comes back denied for the piece nobody tracked.

4. Hold the Start Until Every Required Auth Is In Hand

The hardest call in home infusion is when to start a patient whose therapy is only half authorized. Treating unauthorized and fighting the denial later trades a clean approval for an appeal you may lose, and a write-off on dollars you already spent on drug and nursing. The safer move is a documented rule: which therapies can start on which approvals, which must wait for both, and who makes the call, so a rushed start does not become an unbillable one. Where the clinical urgency is real, that decision is made on the record, not by accident.

5. Hand Split-Benefit Intake to a Dedicated Team

Pharmacies that stop losing starts to the split do it by handing dual-benefit verification and authorization to a dedicated team: remote specialists who verify both paths, open both auths, match them to the claim, and hold what has to wait, live in 1 to 2 weeks. Intake goes back to onboarding patients instead of chasing the auth nobody opened, a trained backup covers every gap, and the referral that used to start half-covered starts fully covered. Below is what it sounds like when nobody owns this yet, in providers’ own words.

Key Pain Points and Discussions by Providers

real reports from practice staff, lightly edited

“The drug auth came back approved so we started the patient, and then the nursing and per diem claims all denied. Turns out that side ran under the medical benefit and nobody had ever opened an auth for it. We ate weeks of nursing visits because we treated one approval as the whole referral.” – intake lead, home infusion pharmacy

“Every payer splits it differently. One wants the drug on the pharmacy side and everything else medical, the next runs the whole thing medical, and Medicaid is its own animal. My intake team is running two verifications on every referral just to figure out which pieces bill where.” – pharmacy operations manager, infusion pharmacy

“We got the pharmacy PA in a day and thought we were clear. The medical-benefit authorization for the per diem sat unopened for two weeks because it lives in a different portal nobody was watching, and the start slipped while the patient waited.” – reimbursement specialist, home infusion

“The denial was for a nursing component that never had an auth. On paper it looked like a documentation problem, but the real problem was that the referral only ever got half authorized and we shipped anyway.” – billing lead, specialty infusion pharmacy

“I have learned to treat one approval as half a referral, not a green light. Until I can point to an authorization behind the drug, the per diem, and the nursing separately, that patient is not really cleared to start.” – intake supervisor, home infusion pharmacy

Our Answer

Here is what we actually do. A dedicated remote specialist treats every referral as two verifications, checking whether the drug, the per diem, the nursing, and the supplies run under the medical benefit, the pharmacy benefit, or a split, before anything ships. They open and track the medical-benefit and pharmacy-benefit authorizations as separate live tasks, each with its own portal, clock, and owner, then match every approval back to the exact claim components it covers so no line goes out unauthorized. When a required auth is still open, they hold the start against your documented rule instead of treating and fighting the denial later. Our specialists are credentialed professionals, overseas-trained physicians and US-licensed nurses and pharmacists, working inside your intake and billing systems, with AI drafting the first pass and a human verifying every submission. This is our prior authorization support paired with an AI-first workflow, in one paragraph.

Why This Keeps Happening

If one auth was approved, why does the claim still bounce? Because home infusion does not fit inside a benefit model built to be either medical or pharmacy. The same therapy can run under either structure depending on the payer, and the drug frequently bills to the pharmacy benefit on an NCPDP claim while the per diem, nursing, and supplies bill to the medical benefit on a CMS-1500. The National Home Infusion Association has pressed CMS to recognize pharmacy-initiated prior authorization precisely because home infusion does not map cleanly onto processes designed for one benefit or the other. The denial is a split-benefit miss far more often than a coverage dispute.

The volume is the second half of the problem. Every referral now carries two verification jobs and, often, two authorizations in two portals, and intake teams are small. When a therapy splits and only the arriving side gets worked, the other side does not announce itself; it simply is not there when the claim is built. Split billing is especially common with Medicaid and with specialty drugs, exactly the high-cost therapies where a missed component hurts most. Closing that gap without adding headcount is what a dedicated AI prior authorization workflow with human oversight is built to do.

And the cost is not a small write-off. A course of home infusion bundles the drug, per diems, skilled nursing, and supplies across weeks of service, and any component that starts without its authorization is dollars already spent that will not be reimbursed. The drug alone can run into five figures; the nursing and per diem stack on top. A missed medical-benefit auth on a therapy you have already been infusing is not a billing nuisance, it is a start you cannot bill, and the appeal that follows competes with every other task in a two- or three-person intake office.

⚠️ The quiet one that hurts most: The quiet one that hurts most: the referral that looks cleared because one auth came back approved. A pharmacy-benefit PA on the drug feels like a green light, so the patient starts, the nurse visits, and the per diem accrues, all under a medical benefit that was never authorized. It reads on paper like a clean start, but half the therapy is building an unbillable claim in real time. Unless someone verifies both benefit paths and opens both authorizations before the first dose, the most expensive referrals are the ones that start half-covered and nobody notices until the medical claim denies.

Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:

What you tried	What actually happened	Who ended up doing the work
Ran one verification on the benefit the referral arrived under	Missed that the therapy split; the other benefit’s components started unauthorized	Whoever picked up the referral in intake
Started the patient once the drug PA approved	Nursing and per diem billed under an unopened medical auth and denied weeks later	The referral, treated as fully cleared
Treated unauthorized and appealed the denial afterward	Lost the appeal on a component that never had an auth, and wrote off the dollars	The billing team, after the fact
Gave split-benefit intake to a dedicated remote specialist	Both benefit paths verified, both auths opened and tracked, every claim line matched to an approval before the start	Someone whose whole job it is

The Solution

So what does “someone whose whole job it is” look like on a split-benefit referral? The specialist starts where a single verification stops: confirming, per payer, whether the drug, the per diem, the nursing, and the supplies run medical, pharmacy, or split, before anything is scheduled. Then they open each required authorization as its own task, in its own portal, with its own clock, so the medical-benefit auth for the nursing and per diem never sits forgotten behind an approved drug PA. Most split-benefit misses are a verification-and-tracking problem, and that is exactly what dedicated prior authorization support is built to solve, before it ever becomes a denial.

Then comes the part that keeps the claim clean. The specialist matches every authorization back to the exact components it covers, this pharmacy PA behind the drug NDC, this medical auth behind the per diem and skilled nursing, and builds the start against that map. When a required auth is still open, they hold the start on your documented rule and escalate the clinical-urgency calls to your pharmacist instead of shipping and hoping. Your intake team stops discovering missing auths at the denial stage, because the missing auth is caught at intake.

Behind all of it, AI drafts the first pass and a credentialed human verifies. The workflow flags which benefit each component falls under and which authorizations are still open; a person confirms the benefit split is right and owns the hold-or-start decision. Every security control that protects the patient and prescription data moving through that process is documented and auditable, and the whole approach is described on our HIPAA and security page, because moving intake and clinical data through an auth workflow is only safe when the controls are real.

Who Actually Does This Work

Fair question: why would an outsourced team run your split-benefit intake better than your own staff? Because verifying two benefit structures and opening two authorizations per referral is their entire day, not the thing they squeeze between phone calls and deliveries. The people working your intake are credentialed medical professionals: overseas-trained physicians, US-licensed nurses and pharmacists, and PharmDs, all trained in US home infusion, benefit verification, and prior authorization workflows. They know when a payer splits a therapy, which components bill where, and how to run a pharmacy PA and a medical-benefit auth in parallel without one falling through. That is not a generalist task handed to whoever is free; it is a specialty.

We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated virtual staff: 500+ credentialed professionals, 24/7 coverage, and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical pharmacy is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a referral never starts half-covered because the one person who runs intake is on vacation.

And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified for ISO/IEC 27001:2022, HIPAA, and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.

Put the routine and the people together, and a specific list of things simply stops happening.

✓ What stops happening: What stops happening: the referral that starts on one approval and denies on the benefit nobody opened. The medical-benefit auth for nursing and per diem sitting forgotten in a portal no one was watching. The five-figure infusion billed with an unauthorized component. The appeal on a denial that never had an auth behind it. The intake queue where nobody owns the second benefit path, so half of every split therapy quietly starts unbillable.

2-Week Free Trial

Ready to Stop Losing Starts to the Benefit Split?

Book A Strategy Call Request Information

How We Permanently Fix the Process

A person alone is not the fix, and neither is a bot alone. The fix is a documented split-benefit workflow: which payers run which components under which benefit, the exact criteria and portal for each authorization, the rule for when a start can proceed and when it must wait, and the matching map that ties every claim line to an approval, all written down and worked the same way every time. Before we take a single referral for a new pharmacy, we chart how your top payers split their infusion therapies so we can see where starts are actually going unbillable, and we build the workflow against that, not against a generic template.

From there the workflow becomes a living playbook rather than tribal knowledge in one intake coordinator’s head. It records how each payer structures the benefit, which portal holds which authorization, how to match approvals to claim components, and the escalation path when clinical urgency collides with an open auth. It is written down, kept current as payers change their rules, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a split referral never starts half-covered because one person came back to a full queue.

That is the difference between reworking this month’s denials and fixing the process for good, and it is what a dedicated prior authorization partner actually buys you. A coordinator leaving used to mean the second benefit path fell through and starts went unbillable again. Under this model the workflow keeps running, the playbook stays, the backup steps in, and a split-benefit referral stops being the thing that quietly costs you a start.

The Whole Thing in Four Sentences

Home infusion providers keep losing starts to split-benefit prior auth because the same therapy can run under the medical benefit, the pharmacy benefit, or both, and intake often works only the path the referral arrived on, so the drug approves while the nursing and per diem sit unauthorized. Running one verification, starting on the drug PA alone, or treating unauthorized and appealing later all fail the same way. The fix is to verify both benefit structures on intake, run the medical and pharmacy authorizations as two live tasks, match every auth to the claim components it covers, and hold the start until every required auth is in hand. A multi-site home infusion pharmacy runs exactly this model with us today, names withheld, no patient data shown.

If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.

Ready to stop losing starts to the benefit split? Try us risk free: two weeks, your real intake queue, dedicated specialists verifying both benefit paths and tracking every auth, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.

Transparent Weekly Pricing

One Flat Weekly Rate. 45 Hours of Coverage.

No hourly meters, no setup fees, no long-term contracts. Your dedicated team member covers your desk 45 hours every week, and a trained backup steps in at no charge whenever they are out.

Single

$399/ week

One dedicated remote specialist running dual-benefit verification and authorization for every referral, single-site home infusion pharmacy

Cover Both Benefit Paths on Every Start This Month

You have seen the whole method. The pilot proves it on your own intake queue, with a tracker your team can watch every day.

Start My 2-Week Free Trial

Request Information or call directly: (800) 489-5877

Request Information

Single specialty or multi-site? One payer or many? Tell us your situation and we will map the right coverage within 24 hours.

Frequently Asked Questions

Why does an infusion claim deny after the drug prior auth was approved?

Because home infusion often splits across two benefits, and the drug PA only covers the drug. Many payers, and especially Medicaid, run the drug under the pharmacy benefit on an NCPDP claim while the per diem, skilled nursing, and supplies bill under the medical benefit on a CMS-1500. If intake only opened the pharmacy PA, the medical-benefit components start unauthorized and deny later. One approval is half the referral, not the whole thing.

How do I know whether a therapy runs under the medical or the pharmacy benefit?

You verify both on intake, per payer, before anything ships. The split is driven by the patient’s plan: some payers run the whole therapy medical, some run the drug pharmacy and the rest medical, and Medicaid frequently splits it. The only safe practice is to check both benefit structures at intake and open an authorization for every component that needs one, rather than assuming the benefit from how the referral arrived.

What is the risk of starting a patient on only one authorization?

You risk infusing a therapy whose other half is unbillable. If the nursing and per diem run under a medical benefit that was never authorized, those visits accrue as an unbillable claim while the patient is treated, and an appeal on a component that never had an auth usually loses. The dollars are already spent on drug and nursing, so the write-off can equal the profit on that patient. A documented hold-or-start rule prevents it.

Can outsourced specialists work inside our intake and billing systems?

Yes. Our specialists work inside the intake, verification, and billing platforms you already use, so there is no migration and no new system for your staff to learn. They verify both benefit paths, open and track both authorizations in the payer portals you already have, and match approvals to claim components where your data already lives, which is why a typical pharmacy is live in 1 to 2 weeks rather than months.

Will AI be deciding which benefit our claims bill under?

No. AI drafts the first pass, flagging which components likely fall under which benefit and which authorizations are still open, and a credentialed human verifies the split, opens the authorizations, and owns the hold-or-start decision. The judgment stays with people. Automation removes the repetitive verification and tracking work so the specialist spends their time on the referrals that need a human, not on retyping the same benefit checks.

How does this handle Medicaid split billing specifically?

Medicaid frequently distinguishes the pharmacy benefit from the medical benefit, so the drug goes to the PBM on an NCPDP claim and the service, supply, and equipment portion goes on a CMS-1500. Our specialists verify the Medicaid benefit structure on intake, open the authorization on each side, and match every claim line to its approval, so the split that trips up so many Medicaid infusion claims is handled before the start rather than at the denial.

How fast will we see fewer half-authorized starts?

Usually within the first two weeks. Once a dedicated specialist is verifying both benefit paths at intake and tracking each authorization as its own task, the referrals that used to start on one approval and deny on the other start reaching the pharmacy fully covered, and the medical-benefit auths that used to sit forgotten in a separate portal get opened before the first dose.

Do we have to change how our pharmacy is staffed to do this?

No. The dedicated team works alongside your existing intake and billing staff, taking the dual-benefit verification and authorization workload off them, so you are not restructuring your pharmacy. Your team keeps the clinical and patient-facing work and the hold-or-start decisions on urgent therapies, while the specialists own the parallel verification and auth tracking that a small intake office rarely has the hours to run cleanly.

How does one flat weekly rate cover 45 hours every week?

Your dedicated specialist works a 9-hour day, Monday to Friday, which is 45 hours of coverage each week. The ninth hour is part of the flat weekly rate, not billed as overtime. Over a year that is 2,340 hours of coverage, against the standard US full-time work year of 2,080 hours (40 hours x 52 weeks, the same basis the U.S. Office of Personnel Management uses to compute hourly rates of pay). That is how $399 per week works out to $8.87 per hour.

Written By

Dan Nandan

Founder and CEO, Staffingly, Inc. · Piscataway, NJ

Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network in India, and has been featured in Computerworld. He runs the operations and the dedicated virtual teams behind the workflows on this page; the team-voice answers above come from the remote specialists who work them every day.

Connect on LinkedIn

Where the Claims on This Page Come From

Sources & References

National Home Infusion Association, Pharmacy-Initiated Prior Authorization Advocacy. NHIA guidance and CMS advocacy on why home infusion does not fit processes designed separately for medical and pharmacy benefits. nhia.org
National Home Infusion Association, Billing and Reimbursement Training Center. Reference on split billing, benefit verification at intake, and NCPDP versus CMS-1500 claim routing for home infusion. nhia.org
CMS Medicaid Benefit and Drug Coverage Resources. Federal guidance relevant to the pharmacy-benefit versus medical-benefit distinction that drives home infusion split billing. medicaid.gov
MGMA Practice Operations and Prior Authorization Resources. Benchmarks and guidance on authorization workload and patient access for medical group and pharmacy practices. mgma.com
HFMA Revenue Cycle and Denials Management Resources. Guidance on authorization-related denials, appeals workflow, and the revenue impact of missed or split authorizations. hfma.org